Physician profile
Mark A Woods
NPI 1558451435
$4,183.27
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,695 · 2020: $1,488.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $424.77 | 2019-2020 | |
| Daiichi Sankyo INC. | $391.27 | 2019-2020 | |
| Pfizer INC. | $379.28 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $366.64 | 2019-2020 | |
| Glaxosmithkline, LLC. | $257.68 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.24 | 2019-2020 | |
| Lilly USA, LLC | $235.58 | 2019-2020 | |
| Novo Nordisk INC | $226.31 | 2019-2020 | |
| Amgen INC. | $213.96 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $192.51 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $183.67 | 2019-2020 | |
| Amarin Pharma, INC. | $159.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $140.01 | 2019 | |
| Radius Health, INC. | $109.79 | 2019-2020 | |
| Abbvie INC. | $98.97 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $96.82 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $54.81 | 2019 | |
| Circassia INC. | $51.31 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $48.14 | 2019-2020 | |
| Astellas Pharma US INC | $44.93 | 2020 | |
| Janssen Pharmaceuticals, INC | $37.04 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $34.14 | 2020 | |
| Mylan Specialty L.P. | $34.02 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.63 | 2020 | |
| Novartis Pharmaceuticals Corporation | $26.19 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $25.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.76 | 2020 | |
| Vanda Pharmaceuticals INC. | $19.12 | 2020 | |
| Supernus Pharmaceuticals, INC. | $17.27 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.78 | 2020 | |
| Ironshore Pharmaceuticals INC. | $11.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.